Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) is held by 54 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 31 Dec, 2025 | 3,167,231 | 0 | 0.00% | $9,026,608.00 |
| Aquamarine Financial (Cayman) Ltd | 31 Dec, 2025 | 1,973,057 | 0 | 0.00% | $5,623,212.00 |
| SB Capital Management Inc | 31 Dec, 2025 | 1,900,000 | 1,900,000 | 0.00% | $5,415,000.00 |
| Murchinson Ltd. | 31 Dec, 2025 | 1,340,247 | -411,312 | -23.48% | $3,819,704.00 |
| BOOTHBAY FUND MANAGEMENT, LLC | 31 Dec, 2025 | 612,160 | -233,231 | -27.59% | $1,744,656.00 |
| Rathbones Group PLC | 31 Dec, 2025 | 466,036 | 233,018 | 100.00% | $1,328,202.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 259,055 | 259,055 | 0.00% | $738,308.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 196,020 | 84,313 | 75.48% | $558,657.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 150,471 | 2,984 | 2.02% | $428,843.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 147,500 | -1,400 | -0.94% | $420,375.00 |
| Bank Of America Corp /De/ | 31 Dec, 2025 | 142,243 | -157,091 | -52.48% | $405,393.00 |
| Wells Fargo & Company/Mn | 31 Dec, 2025 | 130,586 | 500 | 0.38% | $372,169.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 90,212 | -19,521 | -17.79% | $257,104.00 |
| RBF Capital, LLC | 31 Dec, 2025 | 85,894 | 42,947 | 100.00% | $244,798.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 78,259 | 18,600 | 31.18% | $223,038.00 |
| Squarepoint Ops LLC | 31 Dec, 2025 | 58,272 | 28,406 | 95.11% | $166,075.00 |
| HRT FINANCIAL LP | 31 Dec, 2025 | 46,091 | 46,091 | 0.00% | $131.00 |
| Connor, Clark & Lunn Investment Management Ltd. | 31 Dec, 2025 | 43,735 | 15,492 | 54.85% | $124,645.00 |
| Quadrature Capital Ltd | 31 Dec, 2025 | 41,734 | 41,734 | 0.00% | $118,942.00 |
| XTX Topco Ltd | 31 Dec, 2025 | 38,182 | 38,182 | 0.00% | $108,819.00 |